Noteworthy, in both murine and human PC cells, IL30 stands out as an upstream regulator of key drivers of inflammation, immunity and cancer, such as NFKB1 and BCL2, which in human PC cells can be efficiently suppressed by CRISPR/Cas9-mediated IL30 gene deletion. Here, NFKB1 is linked to cancer.